Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

The novel MMP inhibitor SI-27 exhibits antiangiogenic activity in vitro

March 27, 2002

Oncolytics Biotech's phase I Reolysin study meets primary outcome

March 27, 2002

Positive preclinical results reported for Access's mucositis technology

March 27, 2002

Antitumor lipid-peptide conjugates claimed by Indian research group

March 26, 2002

Selective small-molecule inhibitors of ErbB-2 kinase discovered at Georgetown

March 26, 2002

Novel cancer therapy now available in U.S.

March 26, 2002

Roche's MabThera and Xeloda cleared for new indications in Europe

March 26, 2002

Amsalog well tolerated at oral doses up to 1600 mg/m2 in cancer patients

March 26, 2002

Recent patent covers Agouron's CDK inhibitors

March 25, 2002

Novel GnRH antagonists for sex hormone-dependent conditions identified at GSK

March 22, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...